Many Patients Denied Costly New Cholesterol Drugs

THURSDAY, Sept. 28, 2017 — Expensive new medicines offer hope to patients with uncontrolled “bad” cholesterol, but the high cost keeps many patients from getting them, a new study says.
The injectable drugs — approved for use in the United States…
Source: Topamax